219A.T
Heartseed Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 2,172.00
−2.29%Aug 31, 2026, 07:43 UTC
Heartseed announced clinical trial results for its iPS cell-derived cardiomyocyte product for heart failure, confirming efficacy and safety, and aims to file for approval within the year.
Source:Aug 17, 2026, 22:30 UTC
Heartseed applied to the Tokyo Metropolitan Government for a manufacturing and sales license for regenerative medicine products.